FAIR Health—a nonprofit organization focused on the study of healthcare and health insurance costs and utilization—released a new study, “Dental Services and the Impact of COVID-19: An Analysis of Private Claims,” that looks at the effects…

Smoking cigarettes may have been on the decline for a decade, but two trends have become popular with Californians between the ages of 18 and 25: electronic cigarettes and marijuana.

A collaboration between the FDI World Dental Federation and the International Consortium for Health Outcomes Measurement (ICHOM), have developed a minimum Adult Oral Health Standard Set (AOHSS) for use in clinical practice, research,…

A small Chinese study showed that among those hospitalized with COVID-19, the percentage of those who wore eyeglasses for more than 8 hours per day was less (5.8%) than the rate of myopia in the general population (31.5%). The authors…

The American Dental Association (ADA) has expressed its support of House Bill Small Business PPE Tax Credit Act (HR 7216), which provides a tax credit for small businesses to offset the expense of purchasing personal protective equipment…

Dentists can take advantage of the research and development tax credit (R&D) that other industries have benefitted from for years. These R&D tax credits can amount to dollar-for-dollar savings on federal (and possibly state) income…

The University of Michigan (U-M) School of Dentistry welcomes three new full-time faculty members who specialize in cariology, restorative sciences and oral and maxillofacial surgery. 

A University of Bristol study assessed how much xylitol is released in medicated chewing gum by using a robot to replicate human chewing motion. This development may provide opportunities to refine drug release from gum via this delivery…

Two University of California, San Francisco (UCSF) projects have received funding from the National Institute of Dental and Craniofacial Research to continue studies of hydrogel therapies. The teams hope the projects will lead to…

A Phase 3 clinical trial on a COVID-19 vaccine being developed by AstraZeneca in partnership with Oxford University was put on hold after a participant in the United Kingdom (UK)-based study developed severe spinal cord inflammation. The…